INVESTMENT AGREEMENTInvestment Agreement • September 26th, 2014 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This INVESTMENT AGREEMENT (this “Investment Agreement”) is made as of September 17, 2014 by and between CASI Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Spectrum Pharmaceuticals Cayman, L.P., an Exempted Limited Partnership organized under the laws of the Cayman Islands (the “Investor”).
JOINT FILER AGREEMENTJoint Filer Agreement • September 26th, 2014 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that a single Schedule 13D, or any amendment thereto, relating to the equity securities of CASI Pharmaceuticals, Inc., a Delaware corporation, shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as Exhibit 99.1 to such Schedule 13D.
